24 August 2022>: Clinical Research
Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A Single Center Retrospective Study
Supei Yin ABCDEFG , Ming Tang ABCDE , Zhengsheng Rao ABCD , Ximing Chen ABDDE , Mengjuan Zhang ABCDEFG , Ling Liu ABCDE , Keqin Zhang ABCDEFG*DOI: 10.12659/MSM.937112
Med Sci Monit 2022; 28:e937112
Table 4 Analysis of drug susceptibility and drug resistance rate of common bacteria with positive peritoneal fluid (%).
Drug names | Escherichia coli | Staphylococcus epidermidis | Staphylococcus capitis | Serratia liquefaciens |
---|---|---|---|---|
Penicillin G | – | 100.00% | 94.42% | – |
Ampicillin | 100.00% | 100.00% | 74.56% | – |
Compound trimethoprim | 80.51% | 87.82% | 77.35% | – |
Cefepime | 71.86% | 82.32% | 81.42% | 62.84% |
Ceftiofur | 72.86% | 80.32% | 64.42% | 78.84% |
Ceftriaxone | 62.12% | 84.58% | 79.56% | 56.61% |
Ciprofloxacin | 45.64% | 71.52% | 54.03% | 61.28% |
Norfloxacin | 79.86% | 67.56% | 76.16% | 65.28% |
Ofloxacin | 87.86% | 78.06% | 80.86% | 70.67% |
Amoxicillin-clavulanic acid | 41.96% | 47.46% | 36.26% | 55.38% |
Amikacin | 37.16% | 32.77% | 36.14% | 33.47% |
Piperacillin/tazobactam | 18.62% | 20.62% | 23.62% | 21.08% |
Cefoperazone and sulbactam sodium | 29.52% | 30.70% | 29.31% | 28.75% |
Meropenem | 6.74% | 10.60% | 4.65% | 2.23% |
Imipenem | 2.23% | 6.25% | 4.44% | 4.44% |
Ceftazidime | 10.53% | 20.47% | 19.27% | 11.08% |
Linezolid | 0.00% | 0.00% | 0.00% | 0.00% |
Teicoplanin | 0.00% | 0.00% | 0.00% | 0.00% |
Levofloxacin | 0.00% | 0.00% | 0.00% | 0.00% |
Vancomycin | 0.00% | 3.30% | 0.00% | 0.00% |
Tigecycline | 0.00% | 0.00% | 0.00% | 0.00% |